<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39446709</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3375</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PLOS global public health</Title><ISOAbbreviation>PLOS Glob Public Health</ISOAbbreviation></Journal><ArticleTitle>COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: A repeated cross-sectional study.</ArticleTitle><Pagination><StartPage>e0003028</StartPage><MedlinePgn>e0003028</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0003028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgph.0003028</ELocationID><Abstract><AbstractText>Pregnant women are considered a high-risk group for COVID-19, and a priority for vaccination. Routine antenatal care (ANC) provides an opportunity to track trends and factors associated with vaccine uptake. We sought to evaluate COVID-19 vaccine uptake among pregnant women attending ANC and assess the factors associated with vaccine in Zambia. We conducted a repeated cross-sectional study in 39 public health facilities in four districts in Zambia from September 2021 to September 2022. Pregnant women who were aged 15-49 years were enrolled during their first ANC visit. Every month, ~20 women per facility were interviewed during individual HIV counseling and testing. We estimated vaccine uptake as the proportion of eligible participants who self-reported having received the COVID-19 vaccine. A total of 9,203 pregnant women were screened, of which 9,111 (99%) were eligible and had vaccination status. Of the 9,111 included in the analysis, 1,818 (20%) had received the COVID-19 vaccine during the study period, with a trend of increasing coverage with time (0.5% in September 2020, 27% in September 2022). Conversely, 3,789 (42%) reported not being offered a COVID-19 vaccine. We found that women aged 40-49 years, had no education or attained some primary school education, were not employed, and had prior COVID-19 infection were significantly associated with vaccine uptake. COVID-19 vaccine uptake among pregnant women was lower than estimates from the general population (27% across the four districts in September 2022), pointing to missed opportunities to protect this high-risk group. ANC visits were a viable point for conducting COVID-19 surveillance. Incorporating the vaccine as part of the routine ANC package might increase coverage in this group.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tembo</LastName><ForeName>Tannia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3800-371X</Identifier><AffiliationInfo><Affiliation>Reproductive, Maternal, Newborn and Child Health (RMNCH), Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somwe</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Analysis Unit, Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosomprah</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Analysis Unit, Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health, University of Ghana, Accra, Accra.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heilmann</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalenga</LastName><ForeName>Kalubi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Strategic Information Unit, Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moyo</LastName><ForeName>Nyembezi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0000-3605-9280</Identifier><AffiliationInfo><Affiliation>Strategic Information Unit, Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabamba</LastName><ForeName>Bupe</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>PATH, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seffren</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fwoloshi</LastName><ForeName>Sombo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Teaching Hospital, Ministry of Health, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutagwera</LastName><ForeName>Marie-Reine</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>PATH, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musunse</LastName><ForeName>Maximillian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2583-7881</Identifier><AffiliationInfo><Affiliation>PATH, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwiinga</LastName><ForeName>Linos</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutman</LastName><ForeName>Julie R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hines</LastName><ForeName>Jonas Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikazwe</LastName><ForeName>Izukanji</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3898-2607</Identifier><AffiliationInfo><Affiliation>Center for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Glob Public Health</MedlineTA><NlmUniqueID>9918283779606676</NlmUniqueID><ISSNLinking>2767-3375</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>22</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>22</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446709</ArticleId><ArticleId IdType="pmc">PMC11500936</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0003028</ArticleId><ArticleId IdType="pii">PGPH-D-24-00381</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Global Situation. 2023 [cited 2023 Jul 13]. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Kolb JJ, Radin JM, Quer G, Rose AH, Pandit JA, Wiedermann M. Prevalence of Positive COVID-19 Test Results Collected by Digital Self-report in the US and Germany. JAMA Netw Open [Internet]. 2023. 
Jan
31 [cited 2023 May 28];6(1):e2253800. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800848. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9890282</ArticleId><ArticleId IdType="pubmed">36719683</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Siddique R, Bai Q, Shabana, Liu Y, Xue M, et al.. Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options. Journal of Infection and Public Health [Internet]. 2020. 
Dec [cited 2023 May 28];13(12):1840–4. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1876034120305761. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381894</ArticleId><ArticleId IdType="pubmed">32741731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sh. Nur MA, Dahie HA, Hassan NA, Garba B, Adam MH, Mohamoud JH, et al.. Seroprevalence of SARS-CoV-2 virus antibodies and sociodemographic features of pregnant women in Mogadishu, Somalia: a cross-sectional survey study. BMJ Open [Internet]. 2022. 
Jun [cited 2023 May 28];12(6):e059617. Available from: https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2021-059617

</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-059617</ArticleId><ArticleId IdType="pmc">PMC9185162</ArticleId><ArticleId IdType="pubmed">35680266</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. COVID Data Tracker [Internet]. Atlanta, GA: US Department of Health and Human Services; 2023 [cited 2023 May 7]. https://COVID.cdc.gov/COVID-data-tracker/#datatracker-home.</Citation></Reference><Reference><Citation>Dehingia N, Raj A. Sex differences in COVID-19 case fatality: do we know enough?
The Lancet Global Health [Internet]. 2021. 
Jan [cited 2023 May 28];9(1):e14–5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214109X20304642. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834645</ArticleId><ArticleId IdType="pubmed">33160453</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Uptake of COVID-19 Vaccines among Pregnant Women: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2022. 
May
12;10(5):766. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145279/. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9145279</ArticleId><ArticleId IdType="pubmed">35632521</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015. 
Aug
14;33(34):4161–4. Available from: https://pubmed.ncbi.nlm.nih.gov/25896383/. 
</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>Firouzbakht M, Sharif Nia H, Kazeminavaei F, Rashidian P. Hesitancy about COVID-19 vaccination among pregnant women: a cross-sectional study based on the health belief model. BMC Pregnancy Childbirth [Internet]. 2022. 
Dec [cited 2023 Aug 9];22(1):611. Available from: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-04941-3. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-022-04941-3</ArticleId><ArticleId IdType="pmc">PMC9344440</ArticleId><ArticleId IdType="pubmed">35918665</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardhana N, Baecher K, Boutwell A, Pekwarake S, Kifem M, Ngong MG, et al.. COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa. Sallam M, editor. PLoS ONE [Internet]. 2022. 
Sep
13 [cited 2023 Jun 28];17(9):e0274541. Available from: https://dx.plos.org/10.1371/journal.pone.0274541. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274541</ArticleId><ArticleId IdType="pmc">PMC9469991</ArticleId><ArticleId IdType="pubmed">36099295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Huang Y. COVID-19 Vaccine Hesitancy: The Role of Socioeconomic Factors and Spatial Effects. Vaccines [Internet]. 2022. 
Feb
24 [cited 2023 Jul 13];10(3):352. Available from: https://www.mdpi.com/2076-393X/10/3/352. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8950417</ArticleId><ArticleId IdType="pubmed">35334984</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson L, Dziva Chikwari C, Simms V, Tembo M, Mahomva A, Mugurungi O, et al.. Addressing sociodemographic disparities in COVID-19 vaccine uptake among youth in Zimbabwe. BMJ Glob Health [Internet]. 2023. 
Jul [cited 2023 Jul 13];8(7):e012268. Available from: https://gh.bmj.com/lookup/doi/10.1136/bmjgh-2023-012268. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-012268</ArticleId><ArticleId IdType="pmc">PMC10335587</ArticleId><ArticleId IdType="pubmed">37407229</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedeji-Adenola H, Olugbake OA, Adeosun SA. Factors influencing COVID-19 vaccine uptake among adults in Nigeria. Yunusa I, editor. PLoS ONE [Internet]. 2022. 
Feb
24 [cited 2023 Jul 13];17(2):e0264371. Available from: https://dx.plos.org/10.1371/journal.pone.0264371. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264371</ArticleId><ArticleId IdType="pmc">PMC8870459</ArticleId><ArticleId IdType="pubmed">35202444</ArticleId></ArticleIdList></Reference><Reference><Citation>Centre for Disease Control and Prevention. Pregnancy and Breastfeeding: What You Need to Know. 2023. Pregnancy or Breastfeeding. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html#:~:text=Antibodies%20made%20after%20pregnant%20people,the%20mother%20to%20her%20baby.</Citation></Reference><Reference><Citation>Lamptey E, Senkyire EK, Banoya MT, Yaidoo S. COVID-19 vaccination in pregnancy: A review of maternal and infant benefits. Gynecology and Obstetrics Clinical Medicine [Internet]. 2022. 
Sep [cited 2023 Jul 13];2(3):124–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2667164622000549. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9359937</ArticleId><ArticleId IdType="pubmed">38620770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health. Statment on COVID-19 in Lusaka, Zambia, [Internet]. Facebook. 2021 [cited 2023 Nov 8]. https://www.facebook.com/mohzambia/photos/a.773733439467982/1949793125195335/?type=3.</Citation></Reference><Reference><Citation>Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al.. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ [Internet]. 2020. 
Jun
8 [cited 2023 May 28];m2107. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.m2107. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2107</ArticleId><ArticleId IdType="pmc">PMC7277610</ArticleId><ArticleId IdType="pubmed">32513659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari M, Pormohammad A, Sheikh Neshin SA, Ghorbani S, Bose D, Alimohammadi S, et al.. Clinical characteristics and outcomes of pregnant women with COVID‐19 and comparison with control patients: A systematic review and meta‐analysis. Rev Med Virol [Internet]. 2021. 
Sep [cited 2023 May 28];31(5):1–16. Available from: https://onlinelibrary.wiley.com/doi/10.1002/rmv.2208. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2208</ArticleId><ArticleId IdType="pmc">PMC7883245</ArticleId><ArticleId IdType="pubmed">33387448</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilmann E, Tembo T, Fwoloshi S, Kabamba B, Chilambe F, Kalenga K, et al.. Trends in SARS-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia: A repeated cross-sectional survey, 2021-2022. Siqueira AM, editor. PLOS Glob Public Health [Internet]. 2024. 
Apr
3 [cited 2024 Apr 11];4(4):e0003073. Available from: https://dx.plos.org/10.1371/journal.pgph.0003073. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgph.0003073</ArticleId><ArticleId IdType="pmc">PMC10990173</ArticleId><ArticleId IdType="pubmed">38568905</ArticleId></ArticleIdList></Reference><Reference><Citation>Joi P. GAVI: The Vacicne Alliance. 2022 [cited 2023 Jun 28]. COVID-19 greatly increases risks to pregnant women: largest sub-Saharan study. https://www.gavi.org/vaccineswork/covid-19-greatly-increases-risks-pregnant-women-largest-sub-saharan-study.</Citation></Reference><Reference><Citation>Get ODK Inc. ODK Collect [Internet]. 2024. https://docs.getodk.org/collect-intro/.</Citation></Reference><Reference><Citation>Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res [Internet]. 2017. 
Dec [cited 2023 Nov 20];17(1):88. Available from: http://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-017-2031-8. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-017-2031-8</ArticleId><ArticleId IdType="pmc">PMC5267473</ArticleId><ArticleId IdType="pubmed">28126032</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, et al.. How We Design Feasibility Studies. American Journal of Preventive Medicine [Internet]. 2009. 
May [cited 2023 Dec 4];36(5):452–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0749379709000968

</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859314</ArticleId><ArticleId IdType="pubmed">19362699</ArticleId></ArticleIdList></Reference><Reference><Citation>DHIS2. DHIS2 COVID-19 Vaccine Delivery Toolkit Strengthen national immunization systems, introduce fit-for-purpose digital solutions and leverage local expertise for equitable COVID-19 vaccine delivery [Internet]. 2023 [cited 2023 Nov 7]. https://dhis2.org/covid-vaccine-delivery/.</Citation></Reference><Reference><Citation>World Health Organization. World Health Organization. 2021. Zambia launches the COVID-19 vaccination. https://www.afro.who.int/news/zambia-launches-covid-19-vaccination.</Citation></Reference><Reference><Citation>World Health Organization. WHO policy brief: Reaching COVID-19 vaccination targets [Internet]. Geneva: WHO; 2022 [cited 2023 Jun 28]. Report No.: 2022.1. https://www.who.int/publications/m/item/strategy-to-achieve-global-covid-19-vaccination-bymid-2022. 2.</Citation></Reference><Reference><Citation>Chekol Abebe E, Ayalew Tiruneh G, Asmare Adela G, Mengie Ayele T, Tilahun Muche Z, Behaile T/Mariam A, et al.. COVID-19 vaccine uptake and associated factors among pregnant women attending antenatal care in Debre Tabor public health institutions: A cross-sectional study. Front Public Health [Internet]. 2022. 
Jul
19 [cited 2023 Jun 28];10:919494. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2022.919494/full. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.919494/full</ArticleId><ArticleId IdType="pmc">PMC9343782</ArticleId><ArticleId IdType="pubmed">35928488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardhana N, Baecher K, Boutwell A, Pekwarake S, Kifem M, Ngong MG, et al.. COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, Africa. Sallam M, editor. PLoS ONE. 2022. Sep 13;17(9):e0274541. doi: 10.1371/journal.pone.0274541</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274541</ArticleId><ArticleId IdType="pmc">PMC9469991</ArticleId><ArticleId IdType="pubmed">36099295</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee D, Mukhopadhyay S, Sahana Asmeen M, Javed A. COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals. Glob Ment Health [Internet]. 2021.  [cited 2023 Jun 30];8:e25. Available from: https://www.cambridge.org/core/product/identifier/S205442512100025X/type/journal_article. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267340</ArticleId><ArticleId IdType="pubmed">34258020</ArticleId></ArticleIdList></Reference><Reference><Citation>Duroseau B, Kipshidze N, Limaye RJ. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries. Front Public Health [Internet]. 2023. 
Jan
12 [cited 2023 Jun 30];10:1087138. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2022.1087138/full. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1087138/full</ArticleId><ArticleId IdType="pmc">PMC9878283</ArticleId><ArticleId IdType="pubmed">36711400</ArticleId></ArticleIdList></Reference><Reference><Citation>Makoni M.
The quest for more COVID-19 vaccinations in Africa. The Lancet Respiratory Medicine [Internet]. 2022. 
Jul [cited 2023 Jun 30];10(7):e70–1. Available from: https://linkinghub.elsevier.com/retrieve/pii/S221326002200193X. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129254</ArticleId><ArticleId IdType="pubmed">35623372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawal L, Aminu Bello M, Murwira T, Avoka C, Yusuf Ma’aruf S, Harrison Omonhinmin I, et al.. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Human Vaccines &amp; Immunotherapeutics [Internet]. 2022. 
Jan
31 [cited 2023 Jun 28];18(1):2034457. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2034457. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2034457</ArticleId><ArticleId IdType="pmc">PMC9009957</ArticleId><ArticleId IdType="pubmed">35240908</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudayu TW, Mengistie HT. COVID-19 vaccine acceptance in sub-Saharan African countries: A systematic review and meta-analysis. Heliyon. 2023. Feb;9(2):e13037. doi: 10.1016/j.heliyon.2023.e13037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e13037</ArticleId><ArticleId IdType="pmc">PMC9846884</ArticleId><ArticleId IdType="pubmed">36686610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochola EA. Vaccine Hesitancy in Sub-Saharan Africa in the Context of COVID-19 Vaccination Exercise: A Systematic Review. Diseases [Internet]. 2023. 
Feb
9 [cited 2023 Jun 30];11(1):32. Available from: https://www.mdpi.com/2079-9721/11/1/32. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9944066</ArticleId><ArticleId IdType="pubmed">36810546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinga JN, Sinda LK, Titanji VPK. Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication. Vaccines (Basel). 2021. Feb 19;9(2):175. doi: 10.3390/vaccines9020175</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020175</ArticleId><ArticleId IdType="pmc">PMC7922050</ArticleId><ArticleId IdType="pubmed">33669659</ArticleId></ArticleIdList></Reference><Reference><Citation>Worede DT, Kassahun M, Endalew B. COVID-19 vaccine acceptance and predictors among pregnant women in Ethiopia: Systematic Review and Meta-Analysis. Public Health in Practice [Internet]. 2023. 
Jun [cited 2023 Aug 10];5:100386. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2666535223000320. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10122770</ArticleId><ArticleId IdType="pubmed">37122635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoque AM, Buckus S, Hoque M, Hoque ME, Van Hal G. COVID-19 Vaccine Acceptability Among Pregnant Women at a Primary Health Care Facility in Durban, South Africa. EJMED [Internet]. 2020. 
Oct
30 [cited 2023 Aug 10];2(5). Available from: https://www.ejmed.org/index.php/ejmed/article/view/493.</Citation></Reference><Reference><Citation>Zhang R, Wang C. Risk perception of COVID-19 and its related factors among centralized medical isolation groups in China. Front Psychol [Internet]. 2023. 
Feb
1 [cited 2023 Jun 29];14:1131076. Available from: https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1131076/full. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1131076/full</ArticleId><ArticleId IdType="pmc">PMC9929357</ArticleId><ArticleId IdType="pubmed">36818133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rikitu Terefa D, Shama AT, Feyisa BR, Ewunetu Desisa A, Geta ET, Chego Cheme M, et al.. COVID-19 Vaccine Uptake and Associated Factors Among Health Professionals in Ethiopia. IDR [Internet]. 2021. 
Dec [cited 2023 Jun 29];Volume 14:5531–41. Available from: https://www.dovepress.com/covid-19-vaccine-uptake-and-associated-factors-among-health-profession-peer-reviewed-fulltext-article-IDR. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702775</ArticleId><ArticleId IdType="pubmed">34984008</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Marshoudi S, Al-Balushi H, Al-Wahaibi A, Al-Khalili S, Al-Maani A, Al-Farsi N, et al.. Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study. Vaccines [Internet]. 2021. 
Jun
4 [cited 2023 Jun 29];9(6):602. Available from: https://www.mdpi.com/2076-393X/9/6/602. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8228881</ArticleId><ArticleId IdType="pubmed">34200001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal AHM, Sarkar T, Khan MM, Roy SK, Khan SH, Hasan SMM, et al.. Factors Affecting Willingness to Receive COVID-19 Vaccine Among Adults: A Cross-sectional Study in Bangladesh. Journal of Health Management [Internet]. 2021. 
Oct
14 [cited 2023 Jun 30];097359842110506. Available from: http://journals.sagepub.com/doi/10.1177/09735984211050691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09735984211050691</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al.. Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia. Front Public Health [Internet]. 2020. 
Jul
14 [cited 2023 Jun 30];8:381. Available from: https://www.frontiersin.org/article/10.3389/fpubh.2020.00381/full. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00381/full</ArticleId><ArticleId IdType="pmc">PMC7372105</ArticleId><ArticleId IdType="pubmed">32760691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al.. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Human Vaccines &amp; Immunotherapeutics [Internet]. 2021. 
Jun
3 [cited 2023 Jun 30];17(6):1612–21. Available from: https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1846397.
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1846397</ArticleId><ArticleId IdType="pmc">PMC8115754</ArticleId><ArticleId IdType="pubmed">33242386</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerda AA, García LY. Hesitation and Refusal Factors in Individuals’ Decision-Making Processes Regarding a Coronavirus Disease 2019 Vaccination. Front Public Health [Internet]. 2021. 
Apr
21 [cited 2023 Jun 30];9:626852. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2021.626852/full.
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.626852/full</ArticleId><ArticleId IdType="pmc">PMC8096991</ArticleId><ArticleId IdType="pubmed">33968880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulenga LB, Hines JZ, Fwoloshi S, Chirwa L, Siwingwa M, Yingst S, et al.. Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey. The Lancet Global Health [Internet]. 2021. 
Jun [cited 2023 May 18];9(6):e773–81. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2214109X2100053X. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8382844</ArticleId><ArticleId IdType="pubmed">33711262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobo P, Hines JZ, Chilengi R, Auld AF, Agolory SG, Silumesii A, et al.. Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia. Emerg Infect Dis [Internet]. 2022. 
Oct [cited 2023 Oct 2];28(13). Available from: https://wwwnc.cdc.gov/eid/article/28/13/22-0743_article.htm. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9745228</ArticleId><ArticleId IdType="pubmed">36502463</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhindo R, Okoboi S, Kiragga A, King R, Arinaitwe WJ, Castelnuovo B. COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda. Amuzie CII, editor. PLoS ONE [Internet]. 2022. 
Dec
2 [cited 2023 Aug 31];17(12):e0278692. Available from: https://dx.plos.org/10.1371/journal.pone.0278692. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278692</ArticleId><ArticleId IdType="pmc">PMC9718389</ArticleId><ArticleId IdType="pubmed">36459514</ArticleId></ArticleIdList></Reference><Reference><Citation>Folayan MO, Arije O, Enemo A, Sunday A, Muhammad A, Nyako HY, et al.. Associations between COVID-19 vaccine hesitancy and the experience of violence among women and girls living with and at risk of HIV in Nigeria. African Journal of AIDS Research [Internet]. 2022. 
Oct
2 [cited 2023 Aug 25];21(4):306–16. Available from: https://www.tandfonline.com/doi/full/10.2989/16085906.2022.2118615.
</Citation><ArticleIdList><ArticleId IdType="doi">10.2989/16085906.2022.2118615</ArticleId><ArticleId IdType="pubmed">36189759</ArticleId></ArticleIdList></Reference><Reference><Citation>Worede DT, Kassahun M, Endalew B. COVID-19 vaccine acceptance and predictors among pregnant women in Ethiopia: Systematic Review and Meta-Analysis. Public Health in Practice. 2023. Jun;5:100386. doi: 10.1016/j.puhip.2023.100386</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhip.2023.100386</ArticleId><ArticleId IdType="pmc">PMC10122770</ArticleId><ArticleId IdType="pubmed">37122635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health. Nationwide 10-day COVID-19 Campaign [Internet]. Nationwide 10-day COVID-19 Campaign. 2022 [cited 2023 Jul 13]. https://twitter.com/mohzambia/status/1527013308305391619?lang=en.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>